Therapeutic effects of metabolic cardioprotector containing L-arginine and inosine in elderly patients with ischemic heart disease
DOI:
https://doi.org/10.14739/2310-1237.2012.2.16763Keywords:
endothelial dysfunction, oxidative stress, myocardial ischemia, metabolic cardioprotectorAbstract
Research of an oxidative stress, antioxidant systems, function of vascular endothelium and episodes of myocardial ischemia in 121 elderly patients with IHD (average age 78,75±0,62 years) was performed. Recovery of endothelium-depended vasodilatation, improvement of indexes of nitric oxide metabolism, oxidative stress reduction, decrease of duration and expressiveness of episodes of myocardial ischemia during treatment by metabolic cardioprotector as a part of complex therapy throughout 3 months in these patients were shown.References
Анисимов В.Н. Фундаментальная геронтология на рубеже веков / Анисимов В.Н. // Клиническая геронтология. – 2000. – №1. – С. 25–32.
Горбунов Н.В. Определение стабильных метаболитов оксида азота по Гриссу в биологическом материале / Н.В. Горбунов // Бюллетень экспериментальной биологии и медицины. – 1995. – №7. – С. 40–48.
Карпов Ю.А. Стабильная ишемическая болезнь сердца: стратегия и тактика лечения / Ю.А. Карпов, Е.В. Сорокин. – М.: Реафарм, 2003. – 244 с.
Королюк М.А. Метод определения активности каталазы / Королюк М.А., Иванова Л.И., Майорова И.Т. // Лабораторное дело. – 1988. – №1. – С. 16–19.
Пат. № 13132 (Україна), МПК JOIN 33/48.- (UA). - №200509119 / Колесник Ю.М., Бєленічев І.Ф., Абрамов А.В., Павлов С.В./ Спосіб визначення активності ферменту NO- синтази в гомогенатах тканин. – Заявл. 27.09.2005.
Роль дисфункции эндотелия в генезе сердечно-сосудистых заболеваний / Ельский В.Н., Ватутин Н.Т., Калинкина Н.В., Салахова А.М. // Журн. АМН України. – 2008. – Т. 14, №1. – C. 51–62.
Чевари Сюб Чаба И. Роль супероксиддисмутазы в окислительных процессах в клетке и метод определения ее в биологических материалах / И. Чевари Сюб Чаба, И. Секей // Лаб. дело. – 1988. – №11. – С. 678–681.
A pilot study of L-arginine supplementation on functional capacity in peripheral arterial disease / R.K. Oka, A. Szuba, J.C. Giacomini, J.P. Cooke // Vase. Med. – 2005. – Vol. 10. – P. 265–274.
Age-related changes in the protective effect of chronic administration of L-arginine on post-ischemic recovery of endothelial function / K. Nakamura, S. Al-Ruzzeh, A.H. Chester et al. // Eur.J.Cardiothorac.Surg. – 2003. – Vol. 23. – P. 626–632.
Endothelial dysfunction in hypercholesterolemia is improved by L-arginine administration: possible role of oxidative stress / H. Kawano, T. Motoyama, N. Hirai et al. // Atherosclerosis. – 2002. – Vol. 161. – P. 375–380.
Halliwell B. Free radical in Biology and Medicine / B. Halliwell, M.C. Yutteridge. – Oxford: Clarendon Press, 1999. – 320p.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
